Recall Notices
Metformin Extended Release 7500mg Recall – Granules Pharmaceuticals Inc.
July 07, 2020
Major Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. This lot (Lot#: T-02134, Expiration 09/30/20) was tested and showed results for NDMA, an unexpected impurity, at levels in excess of acceptable limits. Major has agreed to recall this lot. Learn moreMetformin Extended Release 500mg Recall – Major Pharmaceuticals.
July 07, 2020
Major Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. This lot (Lot#: T-02134, Expiration 09/30/20) was tested and showed results for NDMA, an unexpected impurity, at levels in excess of acceptable limits. Major has agreed to recall this lot. Learn moreMetformin Extended Release 500mg and 750mg Recall - Avkare
June 11, 2020
Avkare is voluntarily recalling all non-expired lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg distributed in the United States that were manufactured by Amneal Pharmaceuticals. Learn moreMetformin Extended Release 500mg Recall - Lupin Pharmaceuticals Inc
June 11, 2020
Lupin Pharmaceuticals is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot G901203, Expiration December 2020). Learn moreMetformin Extended Release 500mg – Marksans Pharma / Time-Cap Labs
June 08, 2020
Marksans Pharma is voluntarily recalling a single lot of Metformin Hydrochloride Extended-Release Tablets, USP 500mg (Lot # XP9004), distributed by Time-Cap Labs Inc. Learn moreMetformin Extended Release 500mg and 750mg Recall – Teva/Actavis
June 03, 2020
Teva Pharmaceuticals is voluntarily recalling 14 lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg distributed in the United States under the Actavis Pharma label. Learn moreMetformin Extended Release 500mg and 750mg Recall – Amneal Pharmaceuticals LLC.
June 02, 2020
Amneal Pharmaceuticals is voluntarily recalling all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg. Learn moreMetformin Extended Release 500mg Recall – Apotex Corp.
May 30, 2020
On May 27, 2020, Apotex Corp announced a voluntary recall of all lots of Metformin Hydrochloride Extended-Release Tablets, USP 500mg. Learn moreRanitidine - FDA requests removal of all products from the market
April 02, 2020
On April 1, 2020, the FDA announced that it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. Learn moreThe information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.